Nonspecific macrophage activation by systemic adjuvants. Evaluation by lysosomal enzyme and in vitro tumoricidal activities.

No abstract is available for this paper.

• Publication year

  1976

• Venue

  International Archives of Allergy and Applied Immunology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 786904
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The second generation of EORTC-ECIG experimental screening for systemic immunity adjuvants. Its significance for cancer immunotherapy. A comparison of BCG and its hydrosoluble extract.

  1975cited by this paper
• Tumor cytotoxicity in vitro by macrophages from mice infected with mycobacterium bovis strain BCG.

  1974cited by this paper
• Anti-Tumour Effect In Vitro of Lymphocytes and Macrophages from Mice Treated with Corynebacterium Parvum

  1974cited by this paper
• In vitro inhibition of tumour cell growth and DNA synthesis by peritoneal and lung macrophages from mice injected with corynebacterium parvum

  1974cited by this paper
• Antitumour effects of Corynebacterium parvum in mice.

  1974cited by this paper
• CHARACTERIZATION OF A LYMPHOCYTE FACTOR WHICH ALTERS MACROPHAGE FUNCTIONS

  1973cited by this paper
• CYTOSTATIC ELIMINATION OF SYNGENEIC RAT TUMOR CELLS IN VITRO BY NONSPECIFICALLY ACTIVATED MACROPHAGES

  1973cited by this paper
• An experimental screening for "systemic adjuvants of immunity" applicable in cancer immunotherapy.

  1973cited by this paper
• Water-soluble and lipid-free fraction from BCG with adjuvant and antitumour activity.

  1972cited by this paper
• Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance.

  1972cited by this paper
• Tumour growth and non-specific immunity in rats: the mechanisms involved in inhibition of tumour growth.

  1972cited by this paper
• Macrophage‐mediated cytotoxicity against allogeneic target cells in vitro

  1972cited by this paper
• Biological study of a nontoxic, water-soluble immunoadjuvant from mycobacterial cell walls.

  1972cited by this paper
• Levamisole inhibits and cures a solid malignant tumour and its pulmonary metastases in mice.

  1972cited by this paper
• In Vitro Nonimmunologic Destruction of Cells with Abnormal Growth Characteristics by Adjuvant Activated Macrophages 1

  1972cited by this paper
• Endotoxin and double stranded RNA render macrophages cytotoxic.

  1971cited by this paper
• Tumour growth in nematode-infected animals.

  1971cited by this paper
• Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni.

  1971cited by this paper
• Increased survival of Swiss mice given sublethal infections of Trichinella spiralis.

  1970cited by this paper
• Inhibition of Tumour Growth by Administration of Killed Corynebacterium parvum

  1966cited by this paper
• Histochemical Demonstration of Leucocyte Acid Phosphatase in Health and in Disease

  1966cited by this paper

• Non-specific effects of veterinary vaccines: a systematic review.

  2021cites this paper
• Studies on the arginase, 5′-nucleotidase and lysozyme activity by monocytes from visceral leishmaniasis patients

  2012cites this paper
• Down-regulation of Fc receptor expression in guinea pig peritoneal exudate macrophages by muramyl dipeptide or lipopolysaccharide.

  1985cites this paper
• Monoclonal antibody to an alveolar macrophage surface antigen in hamsters.

  1984cites this paper
• Adjuvant immunotherapy with nonviable mycobacterium smegmatis in resected primary lung carcinoma a randomized clinical trial of 219 patients

  1984cites this paper
• Effect of Bacillus Calmette-Guérin infection on delayed footpad reaction to Listeria monocytogenes.

  1984cites this paper
• Effect of rifampin, levamisole, and cytoplasmic protein antigen from Mycobacterium microti on 5'-nucleotidase production by guinea pig macrophages

  1982cites this paper
• Mechanisms of BCG action

  1982cites this paper
• Direct activation of human adherent cells by yeast cell wall in vitro.

  1982cites this paper
• Bacillus Calmette-Guérin as an anti-tumor agent. The interaction with cells of the mammalian immune system.

  1982cites this paper
• [Anti-tumour cytostatic and cytotoxic properties of peritoneal exudate cells of conventional and germ-free mice, stimulated or not by "Corynebacterium parvum" (author's transl)].

  1982cites this paper
• Growth of sarcoma 180 in normal and splenectomized BALB/c mice immunized with BCG.

  1982cites this paper
• Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. I. Effect of BCG on the frequency of cytotoxic T lymphocyte precursors and on the production of helper factors.

  1981cites this paper
• Developments in drugs enhancing the immune responses.

  1981cites this paper
• [Cancer and BCG].

  1981cites this paper
• BCG, Corynebacterium parvum or Mycobacterium leprae added to cultures of BCG-primed mouse spleen cells cause an enhanced primary antibody response in vitro.

  1981cites this paper
• The effect of repeated BCG vaccine administration associated with surgery upon the growth of lung metastases in rats with transplantable Morris 5123 hepatoma.

  1981cites this paper
• Macrophage activation by tuftsin and muramyl-dipeptide

  1981cites this paper
• Effect of lentinan on tumor growth in murine allogeneic and syngeneic hosts

  1980cites this paper
• [Effect of BCG on the growth rate of Sarcoma in normal and splenectomized mice].

  1980cites this paper
• Cytostatic activity of in vitro activated human adherent cells against human tumor cell lines.

  1980cites this paper
• Mechanisms of macrophage activation.

  1980cites this paper
• Induction of cytotoxic peritoneal exudate cells by T-cell immune adjuvants of the beta(1 leads to 3) glucan-type lentinan and its analogues.

  1980cites this paper
• Bacterial endotoxins and host immune responses.

  1979cites this paper
• Effect of immunochemotherapy with OK-432 and yeast cell wall on the activities of peritoneal macrophages of mice.

  1979cites this paper
• Mode of action of a mycobacterial water-soluble adjuvant, MAF3.

  1979cites this paper
• Dose-dependent adjuvant effects of Bacillus Calmette-Guérin on tumor immunity in Lewis rats.

  1979cites this paper
• Stimulation of the reticuloendothelial system of mice by muramyl dipeptide

  1979cites this paper
• Suppressed or enhanced antibody responses in vitro after BCG treatment of mice: importance of BCG viability.

  1979cites this paper
• Killing of untreated target cells by nonimmunized rat macrophages in vitro. I. Studies on the type of effector cells and their capacity to destroy allogeneic target cells.

  1978cites this paper
• Functional and morphologic characteristics of interferon-treated macrophages.

  1978cites this paper
• beta(1 leads to 3) Glucan-mediated augmentation of alloreactive murine cytotoxic T-lymphocytes in vivo.

  1978cites this paper
• Effect of BCG on alloimmune cell-mediated cytotoxicity in (C57BL/6Jfemale x A/Jmale)F1 mice. I. Effect of different BCG treatments on cytotoxicity mediated by T-cells and macrophages.

  1978cites this paper
• Cell populations in experimental contact dermatitis.

  1977cites this paper
• Cytotoxicity of rat macrophages activated by persistent or biodegradable bacterial cell walls

  1977cites this paper
• Studies on the mechanisms of action of BCG

  1976cites this paper